Click Here To Browse Securely

What Is Whistleblowing?

A whistleblower is an employee, former employee, or member of an organization, especially a business or government agency, who reports misconduct to people or entities that have the power and presumed willingness to take corrective action. The misconduct may be a violation of a law, rule, regulation and/or a direct threat to public interest, such as fraud, health/safety violations, and corruption.

Examples of whistleblowers are people who become aware of fraud in matters involving such things as Medicare, Medicaid, and other government programs.  These fraud allegations are often leveled at large corporate entities, and even cities, and other municipalities.

Men and women who blow the whistle on such gross misconduct are actually at the core of how our country fixes problems.  These actions save taxpayer money, and punish the corporate and governmental wrongdoers who misuse the system to their own advantage.  These matters ultimately save taxpayers money, since we all pay taxes to fund government programs and subsidies.

Members of our attorney team are recognized nationally as class action and complex litigation specialists in defective pharmaceuticals and medical devices, toxic chemicals, price-fixing, and antitrust violations. As such, we have the internal expertise and experience to understand the complex underlying factors and issues in whistleblower (Qui Tam) matters.

Whistleblower Lawsuit Brought Against Bank of America for Mishandling of Loan Modification Requests


Former employees of Bank of America have recently filed sworn statements against the bank. According to one report, employees would delay processing of loan modifications, would regularly lie to potential borrowers about the completeness of their applications for loan modifications, and even went so far as to deny the applications after taking out crucial documents.* The company and its officials also offered rewards to certain employees for foreclosing on a certain number of consumers.* Bank of America also allegedly lied to the federal government about its loan modifications.*

In addition, the bank would also attempt to steer consumers away from mortgage modifications under the Home Affordable Modification Program (HAMP).* Instead of HAMP modifications, Bank of America would talk consumers into contracts that were much more favorable to it.* As in many such situations, if an employee were to dispute or challenge the bank’s actions, he or she would be summarily dismissed from the company.*

This is not the first scandal to hit major U.S. banks, nor is it the first to hit Bank of America. Not long ago, it came to light that major banks were engaging in improper “robo-sign” activities, whereby the banks would falsify court records in order to try to foreclose on homes.* With other banks, Bank of America even entered into a settlement with the attorneys general of several states in the wake of the “robo-sign” controversy.*

Many are calling for stronger regulation and oversight of U.S. financial institutions. Whether it will come and whether increased regulation and oversight will help prevent abuse by major banks across the nation is still to be determined.

This case is a strong display of the power of inside “whistleblowers” to curb corporate wrongdoing.  Audet and Partners, LLP has prosecuted many whistleblower claims.  If you have witnessed similar improper dealing by your employer, please contact us for a free, completely confidential case evaluation at 800.965.1461. Alternatively, please click here to complete and submit our confidential inquiry form and request a free case evaluation.

*Bank of America Whistleblowers Allege Rot at the Core of the Mortgage Industrial Complex, (Huffington Post, June 20, 2013),

Whistleblower Sales Reps for “Off-label” Drug Sales?


The United States federal government is aggressively pursuing criminal and civil whistleblower cases against pharmaceutical companies for promoting off-label uses of prescription drugs. Between 2003 and 2008, U.S. federal prosecutors and state attorneys general brought more than a dozen cases against drug makers for off-label marketing and won more than $6 billion in criminal and civil settlements

As you know, off-label use is the practice of prescribing pharmaceuticals for a purpose outside the scope of a drug’s approved label, most often concerning the drug’s indication.

It is legal in the United States and in many other countries to use drugs off-label, including controlled substances such as opiates, even though it is a common misconception that it is unlawful to do so.

However, it is unlawful to market, advertise or otherwise promote the off-label use of drugs, including controlled substances.

Read more: (this is our companion website to this site).

Whistleblower catches Dallas, other cities in questionable ambulance billing


Douglas Moore was a fraud investigator for Dallas when he noticed something wrong with the way the city billed Medicare and Medicaid for city-dispatched 911 ambulance calls.

All calls were being billed as more expensive advanced life support calls, though some of them were basic life support calls, according to a whistleblower lawsuit Moore filed.

When Moore brought the improper billing to the city’s attention in April 2009, he was told that because all the city’s ambulances are equipped for advanced life support, the city had been billing every call at the higher rate for a long time.

Read more:

LabCorp pays out $50 million to settle Medicaid fraud allegations


Laboratory Corp. of America Holdings (NYSE:LH) agreed on a $50 million settlement on a whistleblower lawsuit accusing the company of overcharging Medicaid and giving kickbacks in exchange for referrals for its lab tests.

The complaint accused LabCorp of charging California’s Medicaid program prices as much as five times higher than it charged other customers and offered discounted or free tests to health care providers in exchange for referrals.

“Medical providers and professionals who attempt to abuse Medi-Cal are draining healthcare resources from the millions of California families and children who rely on the program,” California Attorney General Kamala Harris said.

Read more:

Ex-Walgreen druggist gets $1.2M in firing suit


A federal court jury in Fresno has awarded more than $1.2 million to a one-time Walgreen pharmacist who says he was fired for reporting Medicare fraud at several California stores.

The Fresno Bee reports that Sami Mitri sued the country’s largest drugstore chain under the federal whistleblower statute claiming his January 2010 firing was in retaliation for calling attention to illegal billing practices.

Walgreen Co. said in court documents that Mitri was fired for working beyond his scheduled shifts even after being told to stop while the company was trying to curb overtime pay.

Read more:

This Site Is Secure